Retour à l'index des publications
Exporter 24 résultats :
Info sur l'export RTF
×
Si vous exportez vos résultats en RTF et que vous ouvrez le fichier avec Microsoft Word, il faut choisir l'encodage "Occidental (Windows Latin 1)".

Journal Article

  1. [PETI-15]B. Petit, Boschetti, G., Passot, G., Chauvenet, M., Cotte, E., Stroeymeyt, K., Nancey, S., Vaudoyer, D., François, Y., Cabelguenne, D., Glehen, O., Flourié, B., et Moussata, D., « Abdominal necrotic abscess from colonic fistula treated endoscopically », Gastrointest Endosc, vol. 81, 2015.
  2. [BOSC-15a]G. Boschetti, Garnero, P., Moussata, D., Cuerq, C., Préaudat, C., Duclaux-Loras, R., Mialon, A., Drai, J., Flourié, B., et Nancey, S., « Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease », Inflamm Bowel Dis., vol. 21, 2015.
  3. [BOSC-15b]G. Boschetti, Laidet, M., Moussata, D., Stefanescu, C., Roblin, X., Cotte, E., Passot, G., François, Y., Drai, J., Del Tedesco, E., Bouhnik, Y., Flourié, B., et Nancey, S., « Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease », Am J Gastroenterol, 2015.
  4. [MOUS-15a]D. Moussata, Stroeymeyt, K., Boschetti, G., Chauvenet, M., Nancey, S., Berger, F., Lecomte, T., et Flourié, B., « Endoscopic and histologic characteristics of serrated lesions. », World J Gastroenterol., vol. 21, 2015.
  5. [BOSC-14]G. Boschetti, Nancey, S., Moussata, D., Stefanescu, C., Roblin, X., Chauvenet, M., Stroeymeyt, K., Bouhnik, Y., et Flourié, B., « Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment. », Dig Liver Dis, vol. 46, 2014.
  6. [NANC-13c]S. Nancey, Boschetti, G., Moussata, D., Cotte, E., Peyras, J., Cuerq, C., Haybrard, J., Charlois, A. - L., Mialon, A., Chauvenet, M., Stroeymeyt, K., Kaiserlin, D., Drai, J., et Flourié, B., « Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases », Inflamm Bowel Dis., vol. 19, p. 10, 2013.
  7. [JOUE-13]P. Jouët, Moussata, D., Duboc, H., Boschetti, G., Attar, A., Gorbatchef, C., Sabaté, J. - M., Coffin, B., et Flourié, B., « Effect of short-chain fatty acids and acidification on the phasic and tonic motor activity of the human colon. », Neurogastroenterol Motil., vol. 25, p. 7, 2013.
  8. [NANC-13b]S. Nancey, Boschetti, G., Moussata, D., Hequet, O., Roblin, X., et Flourié, B., « Letter: extracorporeal photopheresis in refractory chronic active ulcerative colitis », Aliment Pharmacol Ther., vol. 38, 2013.
  9. [NANC-13]S. Nancey, Boschetti, G., Moussata, D., Cotte, E., Peyras, J., Cuerq, C., Haybrard, J., Charlois, A. L., Mialon, A., Chauvenet, M., Stroeymeyt, K., Kaiserlian, D., Drai, J., et Flourié, B., « Neopterine is a novel reliable fécal marker as accurate as calprotectine for predicting endoscopic disease activity in patients with inflammatory bowel diseases. », Inflamm Bowel Dis, 2013.
  10. [PIOC-13]M. Pioche, Boschetti, G., Cotte, E., Graber, I., Moussata, D., François, Y., Berger, F., Nancey, S., et Flourié, B., « Human herpesvirus 8-associated colorectal Kaposi's sarcoma occurring in a drug-induced immunocompromised patient with refractory ulcerative colitis: Report of a new case and review of the literature. », Inflamm Bowel Dis, 2013.
  11. [MOUS-12b]D. Moussata, Bessayah, A., Chauvenet, M., Stroeymeyt, K., Boschetti, G., Nancey, S., Cotte, E., Glehen, O., Issac, S., Mornex, F., Freyer, G. Lombard-Bohas C, F., Lombard-Bohas, C., et Flourié, B., « A pathologic complete response in the surgical specimen after systemic chemotherapy for a gallbladder carcinoma », Gastrointest Cancer Res, vol. 5, 2012.
  12. [NANC-12]S. Nancey, Boschetti, G., Cotte, E., Ruel, K., Almeras, T., Chauvenet, M., Stroeymeyt, K., Moussata, D., Kaiserlian, D., et Flourié, B., « Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab is associated with a profound long-lasting depletion of Foxp3 (+) regulatory T cells: A mechanistic explanation for ipilimumab-induced severe enterocolitis? », Inflamm Bowel Dis, vol. 18, 2012.
  13. [MOUS-12a]D. Moussata, Amara, S., Decaussin, M., Mornex, F., Gerard, J. P., Romestaing, P., Berger, F., Rödel, F., Flourié, B., Benahmed, M., et Mauduit, C., « XIAP as a radioresistance factor and prognostic marker for radiotherapy in rectal adenocarcinoma.  », Am J Pathol. , vol. 181, 2012.
  14. [MOUS-11]D. Moussata, Goetz, M., Gloeckner, A., Kerner, M., Campbell, B., Hoffman, A., Biesterfeld, S., Flourié, B., Saurin, J. C., Galle, P. R., Neurath, M. F., Watson, A. J., et Kiesslich, R., « Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo. », Gut, vol. 60, 2011.
  15. [BOSC-11]G. Boschetti, Cotte, E., Moussata, D., Chauvenet, M., Breysse, F., Chomarat, M., Isaac, S., Berger, F., Kaiserlian, D., Nancey, S., et Flourié, B., « Identification of Mycobacterium cosmeticum sp. as a novel colitogenic infectious agent in a nonimmunocompromised patient. », Inflamm Bowel Dis, vol. 17, 2011.
  16. [VIEN-09]S. Viennot, Deleporte, A., Moussata, D., Nancey, S., Flourié, B., et Reimund, J. - M., « Colon cancer in inflammatory bowel disease: recent trends, questions and answers. », Gastroenterol Clin Biol, vol. 33, 2009.
  17. [NANC-09]S. Nancey, Moussata, D., Roman, S., Benmansour, H., Claudel, S., et Flourié, B., « A positive breath hydrogen test does not predict the occurrence of a spontaneous bacterial peritonitis in cirrhotic patients with ascites. », Digestion, vol. 79, p. 8, 2009.
  18. [NANC-08a]S. Nancey, Perret-Liaudet, A., Moussata, D., Graber, I., Boschetti, G., Renaud, B., Kaiserlian, D., Reimund, J. M., et Flourié, B., « Urinary neopterin is a valuable tool in monitoring Crohn's disease activity. », Inflamm Bowel Dis, vol. 14, 2008.
  19. [NANC-08b]S. Nancey, Hamzaoui, N., Moussata, D., Graber, I., Bienvenu, J., et Flourié, B., « Serum interleukin-6, soluble interleukin-6 receptor and Crohn's disease activity.  », Dig Dis Sci, vol. 53, 2008.
  20. [ACHO-07]L. Achour, Nancey, S., Moussata, D., Graber, I., Messing, B., et Flourié, B., « Faecal bacterial mass and energetic losses in healthy humans and patients with a short bowel syndrome. », Eur J clin Nutr, vol. 61, 2007.
  21. [NANC-07]S. Nancey, Moussata, D., et Flourié, B., « Ulcerative colitis and anti-TNFalpha », Gastroenterol Clin Biol, vol. 31, p. 7, 2007.
  22. [NANC-05]S. Nancey, Moussata, D., Roman, S., Andre, F., Bouvier, M., Claudel, S., Descos, L., Andre, C., et Flourié, B., « Food and digestive allergies in adults », Gastroenterol Clin Biol, vol. 29, p. 11, 2005.
  23. [NANC-05]S. Nancey, Moussata, D., Graber, I., Claudel, S., Saurin, J. C., et Flourié, B., « Tumor necrosis factor alpha reduces butyrate oxidation in vitro in human colonic mucosa: a link from inflammatory process to mucosal damage? », Inflamm Bowel Dis, vol. 11, 2005.
  24. [FLOU-03]B. Flourié, Moussata, D., Nancey, S., Bonvoisin, S., Benhamed, M., et Descos, L., « Cancer and inflammatory bowel diseases », Gastroenterol Clin Biol, vol. 27, p. 7, 2003.